Log in
Login
Password
Remember
Lost password
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Shares  >  Nasdaq  >  EntreMed Inc    

SummaryNewsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Develops pharmaceutical drugs for treating cancer & inflammatory diseases

CASI Pharmaceuticals, Inc. is a biopharmaceutical company focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs with commercial focus on the China market.

The Company operates through one business segment, which is the development of targeted therapeutics primarily for the treatment of cancer.

The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong and Macau.

The drugs are Captisol-Enabled, ZEVALIN and MARQIBO.

CASI Pharmaceuticals was founded in 1991 and is headquartered in Rockville, MD.

Number of employees : 22 persons.
Sales per Businesses
20132014Delta
USD (in Million)%USD (in Million)%
Therapeutics--0.024100%-
Sales per Regions
20132014Delta
USD (in Million)%USD (in Million)%
United States and China--0.024100%-
Managers
NameAgeSinceTitle
Ken Keyong Ren MD, PhD562012Chief Executive Officer & Director
Wei-Wu He PhD, MBA502012Executive Chairman
Cynthia Wong Hu452006COO, Secretary, Vice President & General Counsel
Sara B. Capitelli, CPA482011Chief Accounting Officer & Vice President-Finance
Rong Chen MD, PhD-2015Chief Medical Officer
Tak W. Mak, PhD682012Director
James Z. Huang, MBA492013Independent Director
Yue Alexander Wu PhD, MBA512013Independent Director
Franklin Cary Salisbury, Jr.592014Independence Director
Rajesh C. Shrotriya, MD712014Independent Director
Shareholders
NameShares%
IDG Capital Partners Co., Ltd. 6,842,783 21.1%
Spectrum Pharmaceuticals, Inc. 5,405,382 16.7%
Wellington Shields Capital Management LLC 591,695 1.82%
Wellington Shields & Co. LLC 489,372 1.51%
Emerging Technology Partners LLC 441,072 1.36%
Kleiner Perkins Caufield & Byers LLC 416,666 1.28%
The Vanguard Group, Inc. 405,060 1.25%
Tak W. Mak, PhD 365,376 1.13%
BlackRock Fund Advisors 261,556 0.81%
Sabby Capital LLC 243,201 0.75%
Sector
Healthcare
Pharmaceuticals & Medical Research
 Biotechnology & Medical Research
  Biotechnology & Medical Research
   Biotechnology & Medical Research - NEC
Advertisement
Sector Biotechnology & Medical Research
Growth (Revenue) Profitability
INCYTE CORPORATIO..
ALKERMES PLC
QUINTILES TRANSNA..
ALNYLAM PHARMACEU..
UNITED THERAPEUTI..
CELLTRION, INC.
QIAGEN NV
ISIS PHARMACEUTIC..
ANACOR PHARMACEUT..
SEATTLE GENETICS,..
INTREXON CORP
ICON PLC
PAREXEL INTERNATI..
ACADIA PHARMACEUT..
BIO-TECHNE CORP
BB BIOTECH AG
CHARLES RIVER LAB..
WUXI PHARMATECH (..
NOVAVAX, INC.
PUMA BIOTECHNOLOG..
-
Sector Biotechnology & Medical Research
EntreMed Inc : Connections
Wuhan Kindstar Diagnostics Co., Ltd.
ImmunoVentis, Inc.
Cytomyx Holdings Plc
American Academy of Arts & Sciences
OriGene Technologies, Inc.
Crown Bioscience, Inc.
Intradigm Corp.
Amnis Corp.
University of Toronto
MithraGen, Inc.
National Academy of Sciences
Emerging Technology Partners LLC
KPCB China Fund II LP
Miikana Therapeutics, Inc.
National Foundation for Cancer Research
The Campbell Family Institute for Breast Cancer Research
Allos Therapeutics, Inc.
Company contact information
CASI Pharmaceuticals, Inc.
9620 Medical Center Drive
Suite 300
Rockville, MD 20850

Phone : +1.240.864.2600
Fax : +1.240.315.2437
Web : www.casipharmaceuticals.com
© 2015 People , Fundamentals and Ownership